| 中文名称: | TSU-68 (SU6668, Orantinib) |
| 中文别名: | 2-甲基-6-[(3-甲氧基苯基)乙烯基]吡啶;5-[(1,2-二氢-2-氧代-3H-吲哚-3-基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸;5-[(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸;TSU-68 (SU6668, Orantinib) 抑制剂 |
| smiles: | CC1=C(/C=C2C3=CC=CC=C3NC/2=O)NC(C)=C1CCC(O)=O |
| 英文名称: | TSU-68 (SU6668, Orantinib) |
| 英文别名: | 3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;TSU-68 (SU6668, Orantinib);(E)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;1H-Pyrrole-3-propanoicacid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;3-{2,4-dimethyl-5-[(2-oxo(1H-benzo[d]azolidin-3-ylidene))-methyl]pyrrol-3-yl}propanoic acid;5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-Pyrrole-3-propanoic acid;orantinib;SU 6668;TSU-68;TSU-68 (SU6668);TSU68;SU-6668;5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid;Orantinib;210644-62-5;J-502593;SCHEMBL134661;HMS3677J06;252916-29-3;NSC 702827;EX-A471;3-(2,4-DIMETHYL-5-(((3Z)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID;(Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid;NSC-763929;NS00069381;SW219790-1;Orantinib (SU6668);CCG-267578;ORANTINIB [WHO-DD];UNII-9RL37ZZ665;Orantinib; SU-6668;SU006668;NSC-800809;3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid;SMR004702878;1044712-39-1;AKOS024457561;TSU 68;DTXSID101017164;245036-27-5;2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid;3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid;BDBM4811;Orantinib (TSU-68);3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid;TSU-68 (Random Configuration);BRD-K55966568-001-01-3;Pdgfr tyrosine kinase inhibitor vi,su6668;3-{2,4-Dimethyl-5-[(Z)-(2-Oxo-1,2-Dihydro-3h-Indol-3-Ylidene)methyl]-1h-Pyrrol-3-Yl}propanoic Acid;PDGFR Tyrosine Kinase Inhibitor VI, SU6668 - CAS 210644-62-5;NSC763929;(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid;1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;SU6668;MFCD09743433;Orantinibum;5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid;Orantinib (TSU-68, SU6668);MLS006011090;3-[2, 4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid;NCGC00387029-01;AC-25028;CS-0197;5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid;PDGFR Tyrosine Kinase Inhibitor VI, SU6668;HY-10517;HMS3413J06;s1470;(z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1h-pyrrol-3-yl]-propionic acid;NSC-702827;3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid;NSC800809;J-013813;1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;CHEMBL274654;DB12072;3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone;1H-Pyrrole-... |
| CAS号: | 252916-29-3 |
| 分子式: | C18H18N2O3 |
| 分子量: | 310.35 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
TSU-68 (SU6668, Orantinib)
英文名:
TSU-68 (SU6668, Orantinib)
别名:2-甲基-6-[(3-甲氧基苯基)乙烯基]吡啶;5-[(1,2-二氢-2-氧代-3H-吲哚-3-基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸;5-[(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸;TSU-68 (SU6668, Orantinib) 抑制剂
商品编号:R032503-100mg
规格:100mg
纯度:99%
CAS号: 252916-29-3
分子式:C18H18N2O3
分子量:310.35
| 价格 |
¥ 3559.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















